ex scientia

ex scientia is a technology platform company operating at the IT/healthcare interface with the goal of revolutionising productivity by the use of data analytics and machine learning in drug design and pharmacogenomics. ex scientia seeks to exploit its unique, proprietary state-of-the-art computational technology, invented in the Hopkins Lab, to discover drugs against pharmacogenomic profiles of multiple drug targets (polypharmacology).